EVH logo

EVHEvolent Health Inc - Ordinary Shares - Class A

$4.47
$0.25
(5.30%)
Today
Closed $4.47
$0.02
(0.45%)
After Hours
Updated: 07:51 PM EDT
EarningsAug 6
Mkt Cap$530.91M
Vol1.9M
News
all
press releases
Veeva's Falcon and Vault AI: When Could AI Become a Revenue Driver?
VEEV's Falcon and Vault AI deepen workflow automation across life sciences, while management expects AI revenues to remain immaterial in fiscal 2027.
Zacks
News Placeholder
More News
News Placeholder
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer
Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer Quest Analytics Expands Leadership Team with Appointment of Chris Lance as Chief Product Officer PR...
PR Newswire
News Placeholder
Compared to Estimates, Evolent Health (EVH) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Evolent Health (EVH) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks
News Placeholder
Evolent Health (EVH) Reports Q1 Loss, Misses Revenue Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of +57.17% and -6.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Evolent Announces First Quarter 2026 Results
Evolent Announces First Quarter 2026 Results Evolent Announces First Quarter 2026 Results PR Newswire WASHINGTON, May 7, 2026 WASHINGTON, May 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH...
PR Newswire
News Placeholder
Evolent Health (NYSE:EVH) Shares Cross Above Fifty Day Moving Average - Here's Why
Evolent Health (NYSE:EVH) Stock Price Crosses Above 50-Day Moving Average - Here's What Happened...
MarketBeat
News Placeholder
Evolent Health, Inc (NYSE:EVH) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Evolent Health, Inc (NYSE:EVH - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the seventeen research firms that are presently covering the firm...
MarketBeat
News Placeholder
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026
Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 Evolent To Release First Quarter 2026 Financial Results on Thursday, May 7, 2026 PR Newswire WASHINGTON, April 7, 2026 WASHINGTON, April 7, 2026 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a company focused on...
PR Newswire
News Placeholder
Tuesday's ETF Movers: IHF, URA
In trading on Tuesday, the iShares U.S. Healthcare Providers ETF is outperforming other ETFs, up about 3.3% on the day. Components of that ETF showing particular strength include shares of Alignment Healthcare, up about 17.7% and shares of Evolent Health, up about 12.1% on the...
Nasdaq News: Markets
News Placeholder
Evolent Health, Inc (NYSE:EVH) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Evolent Health, Inc (NYSE:EVH - Get Free Report) has earned an average rating of "Moderate Buy" from the seventeen analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and thirteen have given...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.